mRNA |
PD-0332991 |
FIMM |
pan-cancer |
AAC |
0.058 |
0.7 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |